$CBL
CBL & ASSOCIATES PROPERTIES INC

2021 Q3 Form 10-Q Financial Statement

#000156459021044707 Filed on August 16, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 Q2 2020 Q2
Revenue $150.4M $136.6M $124.2M
YoY Change 15.76% 9.94% -35.77%
Cost Of Revenue $47.26M $43.52M $40.79M
YoY Change 2.65% 6.7% -28.42%
Gross Profit $103.1M $93.04M $83.43M
YoY Change 22.96% 11.53% -38.84%
Gross Profit Margin 68.57% 68.13% 67.16%
Selling, General & Admin $13.50M $11.27M $10.87M
YoY Change 7.29% 3.67% -24.66%
% of Gross Profit 13.09% 12.11% 13.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $46.48M $47.50M $52.66M
YoY Change -13.09% -9.81% -18.32%
% of Gross Profit 45.07% 51.05% 63.13%
Operating Expenses $59.98M $58.77M $63.78M
YoY Change -9.2% -7.85% -64.08%
Operating Profit $43.14M $34.28M $19.65M
YoY Change 142.34% 74.42% -147.78%
Interest Expense $19.04M $22.30M $52.63M
YoY Change -68.86% -57.63% 0.28%
% of Operating Profit 44.14% 65.06% 267.83%
Other Income/Expense, Net -$22.84M -$43.49M -$71.31M
YoY Change -55.85% -39.01% 56.59%
Pretax Income -$44.12M -$8.856M -$56.68M
YoY Change 0.54% -84.37% 96.28%
Income Tax -$1.234M $705.0K $16.12M
% Of Pretax Income
Net Earnings -$41.72M -$8.882M -$70.23M
YoY Change -2.7% -87.35% 190.48%
Net Earnings / Revenue -27.74% -6.5% -56.54%
Basic Earnings Per Share -$0.21 -$0.05
Diluted Earnings Per Share -$212.4K -$0.05 -$365.8K
COMMON SHARES
Basic Shares Outstanding 196.4M 196.5K 192.0M
Diluted Shares Outstanding 196.5K 196.5K

Balance Sheet

Concept 2021 Q3 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $268.0M $143.9M $123.4M
YoY Change 150.9% 16.6% 502.39%
Cash & Equivalents $268.0M $143.9M $123.4M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $72.57M $68.51M $125.9M
Other Receivables $4.050M $2.727M $5.457M
Total Short-Term Assets $344.6M $215.1M $254.8M
YoY Change 55.89% -15.57% 151.21%
LONG-TERM ASSETS
Property, Plant & Equipment $3.280B $3.385B $3.836B
YoY Change -13.13% -11.75% -15.23%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $349.3M $261.1M $453.6M
YoY Change 20.02% -42.44% 67.45%
Other Assets $162.8M $128.3M $26.74M
YoY Change 373.04% 379.97%
Total Long-Term Assets $3.884B $4.049B $4.400B
YoY Change -10.58% -7.98% -11.04%
TOTAL ASSETS
Total Short-Term Assets $344.6M $215.1M $254.8M
Total Long-Term Assets $3.884B $4.049B $4.400B
Total Assets $4.228B $4.264B $4.655B
YoY Change -7.36% -8.4% -7.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $203.1M $188.4M $227.1M
YoY Change -8.51% -17.07% -12.72%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $203.1M $188.4M $227.1M
YoY Change -8.51% -17.07% -12.72%
LONG-TERM LIABILITIES
Long-Term Debt $1.019B $987.6M $3.774B
YoY Change -72.68% -73.83% -2.38%
Other Long-Term Liabilities $2.552B $2.592B
YoY Change
Total Long-Term Liabilities $3.571B $3.579B $3.774B
YoY Change -4.26% -5.16% -2.39%
TOTAL LIABILITIES
Total Short-Term Liabilities $203.1M $188.4M $227.1M
Total Long-Term Liabilities $3.571B $3.579B $3.774B
Total Liabilities $3.773B $3.767B $4.025B
YoY Change -4.52% -6.4% -2.47%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $455.1M $496.9M $630.1M
YoY Change
Total Liabilities & Shareholders Equity $4.228B $4.264B $4.655B
YoY Change -7.36% -8.4% -7.78%

Cashflow Statement

Concept 2021 Q3 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$41.72M -$8.882M -$70.23M
YoY Change -2.7% -87.35% 190.48%
Depreciation, Depletion And Amortization $46.48M $47.50M $52.66M
YoY Change -13.09% -9.81% -18.32%
Cash From Operating Activities $71.67M $67.73M -$358.0K
YoY Change 244.22% -19018.44% -100.51%
INVESTING ACTIVITIES
Capital Expenditures -$8.272M -$6.971M -$13.65M
YoY Change -27.6% -48.94% -44.77%
Acquisitions
YoY Change
Other Investing Activities $103.3M $53.72M -$5.095M
YoY Change 7843.38% -1154.43% -113.38%
Cash From Investing Activities $94.99M $46.75M -$18.75M
YoY Change -1038.19% -349.37% -240.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.948M -10.46M -15.89M
YoY Change -59.43% -34.18% -81.04%
NET CHANGE
Cash From Operating Activities 71.67M 67.73M -358.0K
Cash From Investing Activities 94.99M 46.75M -18.75M
Cash From Financing Activities -7.948M -10.46M -15.89M
Net Change In Cash 158.7M 104.0M -35.00M
YoY Change -1884.14% -397.22% -35098.0%
FREE CASH FLOW
Cash From Operating Activities $71.67M $67.73M -$358.0K
Capital Expenditures -$8.272M -$6.971M -$13.65M
Free Cash Flow $79.94M $74.70M $13.29M
YoY Change 147.91% 461.86% -86.04%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 us-gaap Assets
Assets
4264207000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
18000
CY2021Q2 cbl Debtor In Possession Available For Sale Securities Amortized Cost
DebtorInPossessionAvailableForSaleSecuritiesAmortizedCost
183496000
CY2020Q4 cbl Debtor In Possession Available For Sale Securities Amortized Cost
DebtorInPossessionAvailableForSaleSecuritiesAmortizedCost
233053000
CY2021Q2 cbl Debtor In Possession Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
DebtorInPossessionContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
45279000
cbl Debtor In Possession Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
DebtorInPossessionContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
90043000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P5Y
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P15Y
CY2021Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P20Y
CY2021Q2 us-gaap Land
Land
662045000
CY2020Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
5135074000
CY2020Q4 us-gaap Land
Land
695711000
CY2021Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
4978546000
CY2021Q2 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5640591000
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
196443846
CY2020Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
5830785000
CY2021Q2 cbl Real Estate Investment Property Net Before Development In Process
RealEstateInvestmentPropertyNetBeforeDevelopmentInProcess
3369855000
CY2020Q4 us-gaap Other Receivables
OtherReceivables
5958000
CY2020Q4 cbl Mortgage And Other Notes Receivable
MortgageAndOtherNotesReceivable
2337000
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
279355000
CY2020Q4 cbl Intangible Lease And Other Assets
IntangibleLeaseAndOtherAssets
139892000
CY2021Q2 us-gaap Development In Process
DevelopmentInProcess
15150000
CY2020Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
173387000
CY2021Q2 cbl Liabilities Not Subject To Compromise
LiabilitiesNotSubjectToCompromise
1175960000
CY2020Q4 cbl Liabilities Not Subject To Compromise
LiabilitiesNotSubjectToCompromise
1358218000
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
188368000
CY2021Q2 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2591706000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
183496000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196569917
CY2020Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
233053000
CY2020Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
233071000
CY2020Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
103655000
CY2020Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2551490000
CY2020Q4 cbl Redeemable Noncontrolling Interest Equity Deficit Common Carrying Amount
RedeemableNoncontrollingInterestEquityDeficitCommonCarryingAmount
-265000
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196444452
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
196444452
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61781000
CY2021Q2 us-gaap Equity Method Investments
EquityMethodInvestments
261082000
CY2020Q4 us-gaap Assets
Assets
4443740000
CY2021Q2 us-gaap Available For Sale Securities
AvailableForSaleSecurities
183490000
CY2021Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
68514000
CY2021Q2 us-gaap Other Receivables
OtherReceivables
2727000
CY2021Q2 cbl Mortgage And Other Notes Receivable
MortgageAndOtherNotesReceivable
1912000
CY2021Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2270736000
CY2021Q2 cbl Intangible Lease And Other Assets
IntangibleLeaseAndOtherAssets
217603000
CY2020Q4 cbl Real Estate Investment Property Net Before Development In Process
RealEstateInvestmentPropertyNetBeforeDevelopmentInProcess
3589364000
CY2021Q2 cbl Redeemable Noncontrolling Interest Equity Deficit Common Carrying Amount
RedeemableNoncontrollingInterestEquityDeficitCommonCarryingAmount
-543000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
15000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q4 us-gaap Development In Process
DevelopmentInProcess
28327000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
196569917
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3385005000
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
3617691000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143874000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
987592000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1184831000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
281395000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
108565000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4443740000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
531843000
CY2020Q4 us-gaap Minority Interest
MinorityInterest
2454000
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
534297000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
31661000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1456435000
us-gaap Cost Of Other Property Operating Expense
CostOfOtherPropertyOperatingExpense
42615000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23881000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
259491000
cbl Management Developmentand Leasing Fees Revenues
ManagementDevelopmentandLeasingFeesRevenues
3108000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
95611000
us-gaap Real Estate Tax Expense
RealEstateTaxExpense
36285000
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
19565000
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
17250000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-215348000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-72793000
CY2021Q2 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-230000
CY2021Q2 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
45279000
us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
90043000
us-gaap Gain Loss On Investments
GainLossOnInvestments
55131000
CY2021Q2 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
107000
CY2020Q2 cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
2623000
cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
-192000
cbl Gains Losses On Sales Of Real Estate Asset
GainsLossesOnSalesOfRealEstateAsset
2763000
CY2021Q2 us-gaap Reorganization Items
ReorganizationItems
17073000
us-gaap Reorganization Items
ReorganizationItems
40006000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
705000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16117000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4275000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6079000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-43493000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-71313000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-9561000
CY2020Q2 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-2077000
CY2021Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-449000
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-487000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-8882000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-70229000
CY2020Q2 cbl Preferred Dividends Undeclared
PreferredDividendsUndeclared
11223000
cbl Preferred Dividends Undeclared
PreferredDividendsUndeclared
22446000
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-8882000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-81452000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35645000
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.42
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.18
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
534297000
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.16
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
196458
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
191962
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
196484
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
185547
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-9561000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-72793000
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
27000
CY2020Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
64000
CY2020Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
22000
CY2020Q1 us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
16333947
CY2020Q1 cbl Stock Issued During Period Value Common Stockand Restricted Stock Award Gross
StockIssuedDuringPeriodValueCommonStockandRestrictedStockAwardGross
537000
CY2020Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
116781
CY2020Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
97000
CY2020Q1 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
633000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
390000
CY2020Q1 cbl Adjustments To Additional Paid In Capital Noncontrolling Interest Other
AdjustmentsToAdditionalPaidInCapitalNoncontrollingInterestOther
-60000
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
725091000
CY2020Q2 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-72139000
CY2020Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-64000
CY2020Q2 cbl Stock Issued During Period Value Common Stockand Restricted Stock Award Gross
StockIssuedDuringPeriodValueCommonStockandRestrictedStockAwardGross
2000
CY2020Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
20059
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
379000
CY2020Q2 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
384000
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
94000
CY2020Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
25000
CY2020Q2 cbl Adjustments To Additional Paid In Capital Noncontrolling Interest Other
AdjustmentsToAdditionalPaidInCapitalNoncontrollingInterestOther
-117000
CY2020Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1633345
CY2020Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
14000
CY2020Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5891
CY2021Q1 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-28067000
CY2021Q1 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
3000
CY2021Q1 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
111139
CY2021Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
1000
CY2021Q1 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
304000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
93000
CY2021Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
11000
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
506618000
CY2021Q2 cbl Net Income Loss Excluding Amount Recognized In Temporary Equity
NetIncomeLossExcludingAmountRecognizedInTemporaryEquity
-9491000
CY2021Q2 us-gaap Other Comprehensive Income Other Net Of Tax
OtherComprehensiveIncomeOtherNetOfTax
-27000
CY2021Q2 us-gaap Stock Issued During Period Shares Restricted Stock Award Forfeited
StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited
14326
CY2021Q2 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
18000
CY2021Q2 cbl Amortization Of Deferred Compensation
AmortizationOfDeferredCompensation
256000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition
94000
CY2021Q2 cbl Adjustments To Additional Paid In Capital Noncontrolling Interest Other
AdjustmentsToAdditionalPaidInCapitalNoncontrollingInterestOther
-5000
CY2021Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
343000
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
497084000
us-gaap Profit Loss
ProfitLoss
-37841000
us-gaap Profit Loss
ProfitLoss
-212087000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
95611000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
108565000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1496000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4595000
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
385000
us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-753000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
-192000
us-gaap Gains Losses On Sales Of Other Real Estate
GainsLossesOnSalesOfOtherRealEstate
2763000
cbl Gain Losson Insurance Proceeds
GainLossonInsuranceProceeds
511000
us-gaap Gain Loss On Investments
GainLossOnInvestments
55131000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7351000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5061000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6676000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3797000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
15525000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
41955000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15596000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-19352000
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
87298000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
2111000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-753000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
20784000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11849000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
130497000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
38370000
cbl Payments To Additions To Real Estate Assets
PaymentsToAdditionsToRealEstateAssets
13836000
cbl Payments To Additions To Real Estate Assets
PaymentsToAdditionsToRealEstateAssets
36413000
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
5612000
us-gaap Proceeds From Sale Of Real Estate Heldforinvestment
ProceedsFromSaleOfRealEstateHeldforinvestment
3579000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
319887000
us-gaap Share Based Compensation
ShareBasedCompensation
739000
us-gaap Share Based Compensation
ShareBasedCompensation
2293000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
146918000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
400000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
153193000
us-gaap Proceeds From Sale Of Available For Sale Securities
ProceedsFromSaleOfAvailableForSaleSecurities
368380000
us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
600000
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
425000
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
703000
cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
-124000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
1420000
cbl Investments In And Advancesto Subsidiariesand Affiliates
InvestmentsInAndAdvancestoSubsidiariesandAffiliates
10990000
cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
4790000
cbl Distributions In Excess Of Equity In Earnings Of Unconsolidated Affiliates
DistributionsInExcessOfEquityInEarningsOfUnconsolidatedAffiliates
5255000
cbl Debtor Reorganization Items Us Trustee Fees
DebtorReorganizationItemsUSTrusteeFees
1225000
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
920000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
44188000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-191379000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
365000000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
23854000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
120467000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
240000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
5000
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
693000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
87000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
354000
us-gaap Payments Of Distributions To Affiliates
PaymentsOfDistributionsToAffiliates
825000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-24220000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
244079000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
150465000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
91070000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
121722000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59058000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272187000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150128000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
143874000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
123388000
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
100626000
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
249000
CY2021Q2 us-gaap Escrow Deposit
EscrowDeposit
27687000
CY2020Q2 us-gaap Escrow Deposit
EscrowDeposit
26491000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
272187000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150128000
us-gaap Interest Paid Net
InterestPaidNet
26755000
us-gaap Interest Paid Net
InterestPaidNet
51703000
cbl Cash Paid For Reorganization Items
CashPaidForReorganizationItems
35602000
CY2021Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
24
CY2021Q2 cbl Number Of Regional Malls Open Air Centers Owned
NumberOfRegionalMallsOpenAirCentersOwned
61
CY2021Q2 cbl Number Of Regional Malls Open Air Centers Owned
NumberOfRegionalMallsOpenAirCentersOwned
61
CY2021Q2 cbl Number Of Associated Centers Owned
NumberOfAssociatedCentersOwned
23
CY2021Q2 cbl Number Of Associated Centers Owned
NumberOfAssociatedCentersOwned
23
CY2021Q2 cbl Number Of Community Centers Owned
NumberOfCommunityCentersOwned
6
CY2021Q2 cbl Number Of Community Centers Owned
NumberOfCommunityCentersOwned
6
CY2021Q2 cbl Number Of Office Buildings Owned
NumberOfOfficeBuildingsOwned
8
CY2021Q2 cbl Number Of Office Buildings Owned
NumberOfOfficeBuildingsOwned
8
CY2021Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
98
CY2021Q2 us-gaap Reorganization Items
ReorganizationItems
17073000
CY2021Q2 us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
15480000
CY2021Q2 cbl Debtor Reorganization Items Compensation
DebtorReorganizationItemsCompensation
1072000
CY2021Q2 cbl Debtor Reorganization Items Us Trustee Fees
DebtorReorganizationItemsUSTrusteeFees
521000
us-gaap Reorganization Items
ReorganizationItems
40006000
us-gaap Debtor Reorganization Items Legal And Advisory Professional Fees
DebtorReorganizationItemsLegalAndAdvisoryProfessionalFees
37709000
cbl Debtor Reorganization Items Compensation
DebtorReorganizationItemsCompensation
1072000
CY2021Q2 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2591706000
CY2020Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2551490000
CY2021Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
45279000
us-gaap Interest Expense Debt
InterestExpenseDebt
90043000
CY2021Q2 cbl Debtor In Possession Investment In Real Estate Assets Gross
DebtorInPossessionInvestmentInRealEstateAssetsGross
4000429000
CY2020Q4 cbl Debtor In Possession Investment In Real Estate Assets Gross
DebtorInPossessionInvestmentInRealEstateAssetsGross
4056257000
CY2021Q2 cbl Debtor In Possession Accumulated Depreciation
DebtorInPossessionAccumulatedDepreciation
-1557473000
CY2020Q4 cbl Debtor In Possession Accumulated Depreciation
DebtorInPossessionAccumulatedDepreciation
-1544800000
CY2021Q2 cbl Debtor In Possession Investment In Real Estate Net
DebtorInPossessionInvestmentInRealEstateNet
2442956000
CY2020Q4 cbl Debtor In Possession Investment In Real Estate Net
DebtorInPossessionInvestmentInRealEstateNet
2511457000
CY2021Q2 cbl Debtor In Possession Developments In Progress
DebtorInPossessionDevelopmentsInProgress
14215000
CY2020Q4 cbl Debtor In Possession Developments In Progress
DebtorInPossessionDevelopmentsInProgress
27853000
CY2021Q2 cbl Debtor In Possession Investment In Real Estate Assets Net Of Developments In Progress
DebtorInPossessionInvestmentInRealEstateAssetsNetOfDevelopmentsInProgress
2457171000
CY2020Q4 cbl Debtor In Possession Investment In Real Estate Assets Net Of Developments In Progress
DebtorInPossessionInvestmentInRealEstateAssetsNetOfDevelopmentsInProgress
2539310000
CY2021Q2 cbl Debtor In Possession Available For Sale Securities At Fair Value
DebtorInPossessionAvailableForSaleSecuritiesAtFairValue
183490000
CY2020Q4 cbl Debtor In Possession Available For Sale Securities At Fair Value
DebtorInPossessionAvailableForSaleSecuritiesAtFairValue
233071000
CY2021Q2 cbl Debtor In Possession Cash And Cash Equivalents At Carrying Value
DebtorInPossessionCashAndCashEquivalentsAtCarryingValue
131713000
CY2020Q4 cbl Debtor In Possession Cash And Cash Equivalents At Carrying Value
DebtorInPossessionCashAndCashEquivalentsAtCarryingValue
46346000
CY2021Q2 cbl Debtor In Possession Restricted Cash
DebtorInPossessionRestrictedCash
88810000
CY2020Q4 cbl Debtor In Possession Restricted Cash
DebtorInPossessionRestrictedCash
29834000
CY2021Q2 cbl Debtor In Possession Intercompany Due From Non Debtor Entities
DebtorInPossessionIntercompanyDueFromNonDebtorEntities
76365000
CY2020Q4 cbl Debtor In Possession Intercompany Due From Non Debtor Entities
DebtorInPossessionIntercompanyDueFromNonDebtorEntities
76095000
CY2021Q2 cbl Debtor In Possession Intangible Lease And Other Assets
DebtorInPossessionIntangibleLeaseAndOtherAssets
126035000
CY2020Q4 cbl Debtor In Possession Intangible Lease And Other Assets
DebtorInPossessionIntangibleLeaseAndOtherAssets
140241000
CY2021Q2 cbl Debtor In Possession Assets
DebtorInPossessionAssets
3063584000
CY2020Q4 cbl Debtor In Possession Assets
DebtorInPossessionAssets
3064897000
CY2021Q2 cbl Debtor In Possession Other Liabilities
DebtorInPossessionOtherLiabilities
113173000
CY2020Q4 cbl Debtor In Possession Other Liabilities
DebtorInPossessionOtherLiabilities
102910000
CY2021Q2 cbl Debtor In Possession Intercompany Due To Non Debtor Entities
DebtorInPossessionIntercompanyDueToNonDebtorEntities
5771000
CY2020Q4 cbl Debtor In Possession Intercompany Due To Non Debtor Entities
DebtorInPossessionIntercompanyDueToNonDebtorEntities
5062000
CY2021Q2 cbl Debtor In Possession Liabilities Not Subject To Compromise
DebtorInPossessionLiabilitiesNotSubjectToCompromise
118944000
CY2020Q4 cbl Debtor In Possession Liabilities Not Subject To Compromise
DebtorInPossessionLiabilitiesNotSubjectToCompromise
107972000
CY2021Q2 cbl Debtor In Possession Liabilities Subject To Compromise
DebtorInPossessionLiabilitiesSubjectToCompromise
2591706000
CY2020Q4 cbl Debtor In Possession Liabilities Subject To Compromise
DebtorInPossessionLiabilitiesSubjectToCompromise
2551490000
CY2021Q2 cbl Debtor In Possession Shareholders Equity And Non Controlling Interests
DebtorInPossessionShareholdersEquityAndNonControllingInterests
352934000
CY2020Q4 cbl Debtor In Possession Shareholders Equity And Non Controlling Interests
DebtorInPossessionShareholdersEquityAndNonControllingInterests
405435000
CY2021Q2 cbl Debtor In Possession Liabilities And Equity
DebtorInPossessionLiabilitiesAndEquity
3063584000
CY2020Q4 cbl Debtor In Possession Liabilities And Equity
DebtorInPossessionLiabilitiesAndEquity
3064897000
CY2021Q2 cbl Debtor In Possession Revenues
DebtorInPossessionRevenues
90191000
cbl Debtor In Possession Revenues
DebtorInPossessionRevenues
178664000
CY2021Q2 cbl Debtor In Possession Depreciation And Amortization
DebtorInPossessionDepreciationAndAmortization
34228000
cbl Debtor In Possession Depreciation And Amortization
DebtorInPossessionDepreciationAndAmortization
68382000
cbl Debtor In Possession Loss On Impairment
DebtorInPossessionLossOnImpairment
57182000
CY2021Q2 cbl Debtor In Possession Expenses
DebtorInPossessionExpenses
41448000
cbl Debtor In Possession Expenses
DebtorInPossessionExpenses
86839000
CY2021Q2 cbl Debtor In Possession Investment Income Net
DebtorInPossessionInvestmentIncomeNet
1568000
cbl Debtor In Possession Investment Income Net
DebtorInPossessionInvestmentIncomeNet
3356000
CY2021Q2 cbl Debtor In Possession Interest Expense
DebtorInPossessionInterestExpense
395000
cbl Debtor In Possession Interest Expense
DebtorInPossessionInterestExpense
1027000
CY2021Q2 cbl Debtor In Possession Reorganization Items
DebtorInPossessionReorganizationItems
-17073000
cbl Debtor In Possession Reorganization Items
DebtorInPossessionReorganizationItems
-40006000
CY2021Q2 cbl Debtor In Possession Gain Loss On Sales Of Real Estate Assets
DebtorInPossessionGainLossOnSalesOfRealEstateAssets
107000
cbl Debtor In Possession Gain Loss On Sales Of Real Estate Assets
DebtorInPossessionGainLossOnSalesOfRealEstateAssets
-192000
CY2021Q2 cbl Debtor In Possession Income Tax Expense Benefit
DebtorInPossessionIncomeTaxExpenseBenefit
705000
cbl Debtor In Possession Income Tax Expense Benefit
DebtorInPossessionIncomeTaxExpenseBenefit
1456000
CY2021Q2 cbl Debtor In Possession Net Income Loss
DebtorInPossessionNetIncomeLoss
-1983000
cbl Debtor In Possession Net Income Loss
DebtorInPossessionNetIncomeLoss
-73064000
cbl Debtor In Possession Profit Loss
DebtorInPossessionProfitLoss
-73064000
cbl Debtor In Possession Increase Decrease In Loss On Impairment
DebtorInPossessionIncreaseDecreaseInLossOnImpairment
57182000
cbl Debtor In Possession Increase Decrease In Other Operating Assets
DebtorInPossessionIncreaseDecreaseInOtherOperatingAssets
-96277000
cbl Debtor In Possession Net Cash Provided By Used In Operating Activities
DebtorInPossessionNetCashProvidedByUsedInOperatingActivities
80395000
cbl Debtor In Possession Payments To Acquire Available For Sale Securities
DebtorInPossessionPaymentsToAcquireAvailableForSaleSecurities
319887000
cbl Debtor In Possession Redemption Of Available For Sale Securities
DebtorInPossessionRedemptionOfAvailableForSaleSecurities
368380000
cbl Debtor In Possession Payments For Proceeds From Other Investing Activities
DebtorInPossessionPaymentsForProceedsFromOtherInvestingActivities
5437000
cbl Debtor In Possession Net Cash Provided By Used In Investing Activities
DebtorInPossessionNetCashProvidedByUsedInInvestingActivities
43056000
cbl Debtor In Possession Payments Of Net Distributions From Non Debtor Subsidiaries
DebtorInPossessionPaymentsOfNetDistributionsFromNonDebtorSubsidiaries
-20845000
cbl Debtor In Possession Proceeds From Payments For Other Financing Activities
DebtorInPossessionProceedsFromPaymentsForOtherFinancingActivities
47000
cbl Debtor In Possession Net Cash Provided By Used In Financing Activities
DebtorInPossessionNetCashProvidedByUsedInFinancingActivities
20892000
cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
144343000
CY2020Q4 cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
76180000
CY2021Q2 cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220523000
CY2021Q2 cbl Debtor In Possession Cash And Cash Equivalents At Carrying Value
DebtorInPossessionCashAndCashEquivalentsAtCarryingValue
131713000
CY2021Q2 cbl Debtor In Possession Restricted Cash
DebtorInPossessionRestrictedCash
88810000
CY2021Q2 cbl Debtor In Possession Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
DebtorInPossessionCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
220523000
CY2021Q2 cbl Debtor In Possession Cash Paid For Reorganization Items
DebtorInPossessionCashPaidForReorganizationItems
35602000
us-gaap Property Plant And Equipment Impairment
PropertyPlantAndEquipmentImpairment
<p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Arial;font-weight:normal;text-transform:none;font-variant: normal;"><span style="text-decoration:underline;">Carrying Value of Long-Lived Assets and Investment in Unconsolidated Affiliates</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The Company evaluates its real estate assets and investment in unconsolidated affiliates for impairment indicators whenever events or changes in circumstances indicate that the carrying value of any of its long-lived assets or investment in unconsolidated affiliates may not be recoverable. Furthermore, this evaluation is conducted no less frequently than quarterly, irrespective of changes in circumstances. The prolonged outbreak of the COVID-19 pandemic resulted in sustained closure of the Company’s properties for a period of time during 2020, as well as the cessation of the operations of certain of its tenants, which has resulted and will likely continue to result in a reduction in the revenues and cash flows of many of its properties due to the adverse financial impacts on its tenants, as well as reductions in other sources of income generated by its properties. In addition to reduced revenues, the Company’s ability to obtain sufficient financing for such properties may be impaired as well as its ability to lease or re-lease properties as a result of market and economic conditions resulting from the COVID-19 pandemic.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;color:#212529;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">As of June 30, 2021, the Company’s evaluation of impairment of real estate assets considered its estimate of cash flow declines caused by the COVID-19 pandemic, but its other assumptions, including estimated hold period, were generally unchanged given the highly uncertain environment. The worsening of estimated future cash flows due to a change in the Company’s plans, policies, or views of market and economic conditions as it relates to one or more of its properties adversely impacted by the COVID-19 pandemic could result in the recognition of substantial impairment charges on its assets, which could adversely impact its financial results. For the three months ended June 30, 2021, </span><span style="color:#000000;">the Company did not record any impairment charges. For the six months ended June 30, 2021, the Company recorded impairment charges of $57,182 related to three malls. For the three months ended June 30, 2020, the Company recorded an impairment charge of $13,274 related to one mall. For the six months ended June 30, 2020, the Company recorded impairment charges of $146,918 related to three malls.</span></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;text-indent:6.67%;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 30</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, the Company’s estimates of fair value for each investment are based on a number of assumptions that are subject to economic and market uncertainties including, but not limited to, demand for space, competition for tenants, changes in market rental rates, and operating costs. Future declines in the fair value of the Company’s investments in unconsolidated affiliates, including those resulting from the adverse impact of the COVID-19 pandemic on the real estate assets owned by the unconsolidated affiliates, could result in the recognition of substantial impairment charges on its investments in unconsolidated affiliates to the extent such declines are determined to be other-than-temporary. </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">No</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> impairments of investments in unconsolidated affiliates were recorded in the three</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and six</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">month period</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">s</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> ended </span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">June 30</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">, 2021</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> and 20</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20</span><span style="font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
CY2021Q2 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0
CY2021Q2 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2020Q2 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
131316000
CY2020Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
120222000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
259491000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
281395000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3643000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3509000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7759000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8733000
CY2021Q2 us-gaap Revenues
Revenues
136561000
CY2020Q2 us-gaap Revenues
Revenues
124211000
us-gaap Revenues
Revenues
269745000
us-gaap Revenues
Revenues
291785000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
23568000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
46093000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
48128000
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
117789000
CY2021Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
69543000
CY2020Q2 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
99150000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
140770000
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
236544000
CY2021Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
61773000
CY2020Q2 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
21072000
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
118721000
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
44851000
CY2021Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
131316000
CY2020Q2 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
120222000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
259491000
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
281395000
CY2021Q2 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
963118000
CY2020Q4 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1120203000
CY2021Q2 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
27461000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
181159000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
322208000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
270898000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
217637000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
167910000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
120955000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
272145000
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
1552912000
CY2021Q2 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
941440000
CY2020Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
1091745000
CY2021Q2 cbl Estimated Fair Value Of Liabilities Subject To Compromise
EstimatedFairValueOfLiabilitiesSubjectToCompromise
1890020000
CY2020Q4 cbl Estimated Fair Value Of Liabilities Subject To Compromise
EstimatedFairValueOfLiabilitiesSubjectToCompromise
1606959000
CY2021Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
38500000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
cbl Number Of Malls With Impairment
NumberOfMallsWithImpairment
3
CY2020Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
166900000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
146918000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
146918000
cbl Number Of Malls With Impairment
NumberOfMallsWithImpairment
3
CY2021Q2 cbl Number Of Entities Equity Method Of Accounting
NumberOfEntitiesEquityMethodOfAccounting
31
CY2021Q2 cbl Numberof Joint Venture Entities
NumberofJointVentureEntities
17
CY2020Q4 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
68061000
CY2021Q2 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
990579000
CY2021Q2 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0501
CY2020Q4 cbl Long Term Debt Net Excluding Deferred Financing Costs
LongTermDebtNetExcludingDeferredFinancingCosts
1188264000
CY2020Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0510
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
2987000
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
3433000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
987592000
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1184831000
CY2021Q2 cbl Long Term Debt Percentage Bearing Fixed Interest Amount Subject To Compromise
LongTermDebtPercentageBearingFixedInterestAmountSubjectToCompromise
1375000000
CY2020Q4 cbl Long Term Debt Percentage Bearing Fixed Interest Amount Subject To Compromise
LongTermDebtPercentageBearingFixedInterestAmountSubjectToCompromise
1375000000
CY2021Q2 cbl Long Term Debt Percentage Bearing Variable Interest Amount Subject To Compromise
LongTermDebtPercentageBearingVariableInterestAmountSubjectToCompromise
1154138000
CY2020Q4 cbl Long Term Debt Percentage Bearing Variable Interest Amount Subject To Compromise
LongTermDebtPercentageBearingVariableInterestAmountSubjectToCompromise
1114676000
CY2021Q2 cbl Long Term Debt Net Excluding Deferred Financing Costs Subject To Compromise
LongTermDebtNetExcludingDeferredFinancingCostsSubjectToCompromise
2529138000
CY2021Q2 us-gaap Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
0.0723
CY2020Q4 cbl Long Term Debt Net Excluding Deferred Financing Costs Subject To Compromise
LongTermDebtNetExcludingDeferredFinancingCostsSubjectToCompromise
2489676000
CY2020Q4 us-gaap Debtor In Possession Financing Interest Rate On Borrowings Outstanding
DebtorInPossessionFinancingInterestRateOnBorrowingsOutstanding
0.0725
CY2021Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
58370000
CY2020Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
57644000
CY2021Q2 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2591706000
CY2020Q4 us-gaap Liabilities Subject To Compromise
LiabilitiesSubjectToCompromise
2551490000
CY2021Q2 cbl Numberof Malls Securing Credit Facility Collateral
NumberofMallsSecuringCreditFacilityCollateral
17
CY2021Q2 cbl Numberof Associated Centers Securing Credit Facility Collateral
NumberofAssociatedCentersSecuringCreditFacilityCollateral
3
CY2021Q2 cbl Number Of Subsidiaries Owned
NumberOfSubsidiariesOwned
36
cbl Line Of Credit Facility Payment Restrictions
LineOfCreditFacilityPaymentRestrictions
150,000
cbl Number Of Non Recourse Loans
NumberOfNonRecourseLoans
2
CY2021Q2 us-gaap Debt Default Longterm Debt Amount
DebtDefaultLongtermDebtAmount
817757000
cbl Deconsolidation Of Secured Loans Amount
DeconsolidationOfSecuredLoansAmount
138926000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
97868000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
408410000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
1519979000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
343409000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
37624000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
763533000
CY2021Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
3170823000
us-gaap Liabilities Subject To Compromise Period Increase Decrease
LiabilitiesSubjectToCompromisePeriodIncreaseDecrease
2529138000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
97868000
cbl Debt Instrument Weighted Average Remaining Term To Maturity
DebtInstrumentWeightedAverageRemainingTermToMaturity
P2Y7M6D
CY2020 cbl Debt Instrument Weighted Average Remaining Term To Maturity
DebtInstrumentWeightedAverageRemainingTermToMaturity
P3Y
CY2021Q2 us-gaap Revenues
Revenues
136561000
CY2021Q2 cbl Property Operating Expenses
PropertyOperatingExpenses
43517000
CY2021Q2 us-gaap Interest Expense
InterestExpense
22299000
CY2021Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
107000
CY2021Q2 us-gaap Other General Expense
OtherGeneralExpense
287000
CY2021Q2 cbl Segment Profit Loss
SegmentProfitLoss
70565000
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
47499000
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11269000
CY2021Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
57000
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
752000
CY2021Q2 us-gaap Reorganization Items
ReorganizationItems
17073000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
705000
CY2021Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4275000
CY2021Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-9561000
CY2021Q2 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
12287000
CY2020Q2 us-gaap Revenues
Revenues
124211000
CY2020Q2 cbl Property Operating Expenses
PropertyOperatingExpenses
40785000
CY2020Q2 us-gaap Interest Expense
InterestExpense
52631000
CY2020Q2 us-gaap Other General Expense
OtherGeneralExpense
242000
CY2020Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2623000
CY2020Q2 cbl Segment Profit Loss
SegmentProfitLoss
33176000
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
52663000
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18727000
CY2020Q2 us-gaap Investment Income Net
InvestmentIncomeNet
891000
CY2020Q2 us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
13274000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16117000
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-6079000
CY2020Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-72793000
CY2020Q2 us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
11131000
us-gaap Revenues
Revenues
269745000
cbl Property Operating Expenses
PropertyOperatingExpenses
92651000
us-gaap Interest Expense
InterestExpense
46429000
us-gaap Other General Expense
OtherGeneralExpense
287000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-192000
cbl Segment Profit Loss
SegmentProfitLoss
130186000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
95611000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23881000
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-801000
us-gaap Investment Income Net
InvestmentIncomeNet
1528000
us-gaap Reorganization Items
ReorganizationItems
40006000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
57182000
us-gaap Gain Loss On Investments
GainLossOnInvestments
55131000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1456000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7351000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-37841000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
16415000
us-gaap Revenues
Revenues
291785000
cbl Property Operating Expenses
PropertyOperatingExpenses
96150000
us-gaap Interest Expense
InterestExpense
99623000
us-gaap Other General Expense
OtherGeneralExpense
400000
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
2763000
cbl Segment Profit Loss
SegmentProfitLoss
98375000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
108565000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
36563000
us-gaap Investment Income Net
InvestmentIncomeNet
3288000
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
146918000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
16643000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-5061000
us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-212087000
us-gaap Payments For Capital Improvements
PaymentsForCapitalImprovements
31463000
CY2021Q2 us-gaap Assets
Assets
4264207000
CY2020Q4 us-gaap Assets
Assets
4443740000
cbl Environmental Liability Insurance Maximum Coverage Per Incident
EnvironmentalLiabilityInsuranceMaximumCoveragePerIncident
10000
cbl Environmental Liability Insurance Annual Coverage Limit.
EnvironmentalLiabilityInsuranceAnnualCoverageLimit.
50000
CY2021Q2 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
903000
CY2020Q4 us-gaap Guarantees Fair Value Disclosure
GuaranteesFairValueDisclosure
923000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10400000
CY2021Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
2000
CY2020Q2 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
5000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
6000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
12000
CY2021Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1352000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
8332000
cbl Additions To Real Estate Assets Accrued But Not Yet Paid
AdditionsToRealEstateAssetsAccruedButNotYetPaid
14130000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
21051000
us-gaap Noncash Project Abandonment Costs
NoncashProjectAbandonmentCosts
287000
CY2020Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2241421000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
350000000
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
653453000

Files In Submission

Name View Source Status
0001564590-21-044707-index-headers.html Edgar Link pending
0001564590-21-044707-index.html Edgar Link pending
0001564590-21-044707.txt Edgar Link pending
0001564590-21-044707-xbrl.zip Edgar Link pending
cbl-10q_20210630.htm Edgar Link pending
cbl-10q_20210630_htm.xml Edgar Link completed
cbl-20210630.xsd Edgar Link pending
cbl-20210630_cal.xml Edgar Link unprocessable
cbl-20210630_def.xml Edgar Link unprocessable
cbl-20210630_lab.xml Edgar Link unprocessable
cbl-20210630_pre.xml Edgar Link unprocessable
cbl-ex311_11.htm Edgar Link pending
cbl-ex312_8.htm Edgar Link pending
cbl-ex313_9.htm Edgar Link pending
cbl-ex314_10.htm Edgar Link pending
cbl-ex321_7.htm Edgar Link pending
cbl-ex322_6.htm Edgar Link pending
cbl-ex323_12.htm Edgar Link pending
cbl-ex324_13.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending